ADiTx Therapeutics, Inc. Credit Agreements
9 Contracts & Agreements
- Forbearance Agreement and Eight Amendment to Secured Credit Agreement dated as of March 31, 2022 (Filed With SEC on May 16, 2022)
- Forbearance Agreement and Seventh Amendment to Secured Credit Agreement dated as of February 14, 2022 by and among the Company, Cellvera Global Holdings LLC, Cellvera Holdings... (Filed With SEC on March 31, 2022)
- Sixth Amendment to Secured Credit Agreement dated December 28, 2021, by and among AiPharma, AiPharma Holdings Limited, AiPharma Asia Limited and the Company (Filed With SEC on March 31, 2022)
- Fifth Amendment to Secured Credit Agreement dated December 22, 2021, by and among AiPharma, AiPharma Holdings Limited, AiPharma Asia Limited and the Company (Filed With SEC on March 31, 2022)
- Secured Credit Agreement, dated as of December 8, 2021, by and among the Company and the Target Company (Filed With SEC on March 31, 2022)
- Third Amendment to Secured Credit Agreement dated November 30, 2021, by and among AiPharma, AiPharma Holdings Limited, AiPharma Asia Limited and the Company (Filed With SEC on March 31, 2022)
- Second Amendment to Secured Credit Agreement with AiPharma Global Holdings LLC dated October 27, 2021 (Filed With SEC on March 31, 2022)
- First Amendment to Secured Credit Agreement with AiPharma Global Holding LLC (Filed With SEC on November 15, 2021)
- Secured Credit Agreement, dated as of August 27, 2021, by and among AiPharma, AiPharma Holdings Limited, AiPharma Asia Limited and the Company (Filed With SEC on November 15, 2021)
